Biomarin Pharmaceutical (BMRN) Shares Issued (2016 - 2025)
Historic Shares Issued for Biomarin Pharmaceutical (BMRN) over the last 17 years, with Q3 2025 value amounting to $7000.0.
- Biomarin Pharmaceutical's Shares Issued fell 9985.41% to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year decrease of 7229.46%. This contributed to the annual value of $49.3 million for FY2024, which is 2894.76% down from last year.
- Per Biomarin Pharmaceutical's latest filing, its Shares Issued stood at $7000.0 for Q3 2025, which was down 9985.41% from $7.7 million recorded in Q2 2025.
- In the past 5 years, Biomarin Pharmaceutical's Shares Issued ranged from a high of $29.4 million in Q2 2024 and a low of $7000.0 during Q3 2025
- Its 5-year average for Shares Issued is $13.6 million, with a median of $11.3 million in 2022.
- As far as peak fluctuations go, Biomarin Pharmaceutical's Shares Issued skyrocketed by 17445.1% in 2022, and later crashed by 9985.41% in 2025.
- Biomarin Pharmaceutical's Shares Issued (Quarter) stood at $16.3 million in 2021, then surged by 56.08% to $25.5 million in 2022, then tumbled by 41.87% to $14.8 million in 2023, then plummeted by 46.9% to $7.9 million in 2024, then tumbled by 99.91% to $7000.0 in 2025.
- Its Shares Issued was $7000.0 in Q3 2025, compared to $7.7 million in Q2 2025 and $7.9 million in Q4 2024.